SURVIVAL OF BIOLOGICAL AGENTS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: COHORT WITH 13 YEARS OF FOLLOW-UP

被引：0
|
作者：
Freites Nunez, D. [1 ]
Rosales Rosado, Z. [1 ,2 ]
Arietti Lopez, L. [1 ]
Gomez Gomez, A. [1 ]
Pato Cour, E. [1 ]
Fernandez Rueda, J. L. [2 ]
Fernandez Gutierrez, B. [1 ]
Abasolo Alcazar, L. [2 ]
机构：
[1] Hosp Clin San Carlos, Rheumatol, Madrid, Spain
[2] Hosp Clin San Carlos, Fdn Invest Biomed, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0338
引用
收藏
页码：1006 / 1007
页数：2
相关论文
共 50 条
  • [1] ADVERSE EVENTS TO BIOLOGIC AGENTS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: COHORT WITH 13 YEARS OF FOLLOW-UP
    Rosales Rosado, Z.
    Freites Nunez, D.
    Gomez Gomez, A.
    Arietti Lopez, L.
    Macarron Perez, P.
    Leal Pozuelo, J. M.
    Jover Jover, J. A.
    Abasolo Alcazar, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 256 - 256
  • [2] Adverse Events to Biologic Agents in Elderly Patients with Rheumatoid Arthritis: Cohort with 13 Years of Follow-up
    Rosales, Zulema
    Leon, Leticia
    Gomez-Gomez, Alejandro
    Arietti, Lucia
    Pato Cour, Esperanza
    Fernandez Rueda, Jose Luis
    Jover, Juan A.
    Abasolo, Lydia
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] Survival Of Biological Therapy In Rheumatoid Arthritis: 12 Years Follow-up Cohort
    Rosales, Zulema
    Vadillo, Cristina
    Leon, Leticia
    Pena, Rayma
    Blanco, Margarita
    Pato, Esperanza
    Fernandez Rueda, J. L.
    Rodriguez-Rodriguez, Luis
    Fernandez-Gutierrez, Benjamin
    Abasolo, Lydia
    Jover, Juan A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1020 - S1020
  • [4] 4 Years Follow-up of a Cohort of Patients with Rheumatoid Arthritis in Sustained Clinical Remission with Optimization of Biological Therapy
    Lourdes Ladehesa-Pineda, Maria
    Carmen Castro-Villegas, M.
    Romero Gomez, Montserrat
    Perez Sanchez, Clementina Lopez-Medina Laura
    Gomez-Garcia, Ignacio
    Carreto Font, Pilar
    Escudero-Contreras, Alejandro
    Collantes-Estevez, Eduardo
    Font-Ugalde, Pilar
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] 4 YEARS FOLLOW-UP OF A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN SUSTAINED CLINICAL REMISSION AND OPTIMISATION OF BIOLOGICAL THERAPY
    Ladehesa Pineda, M. L.
    Castro Villegas, M. C.
    Romero Gomez, M.
    Bautista Aguilar, L.
    Lopez Medina, C.
    Perez Sanchez, L.
    Gomez Garcia, I.
    Carreto Font, P.
    Escudero Contreras, A.
    Collantes Estevez, E.
    Font Ugalde, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 324 - 324
  • [6] Atherosclerosis in females patients with rheumatoid arthritis; A two years follow-up
    Ferrante, A
    Parrinello, G
    Avellone, G
    Ciccia, F
    Bologna, P
    Giardina, E
    Galante, F
    Giardina, A
    Lipari, L
    Cadelo, M
    Accardo-Palumbo, A
    Licata, G
    Triolo, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 91 - 91
  • [7] Treatment with infliximab in rheumatoid arthritis patients: Two years follow-up
    Almodovar, R
    Joven, BE
    Mateo, I
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 430 - 430
  • [8] Diastolic function abnormalities in rheumatoid arthritis patients: Five years of follow-up
    Yazici, D.
    Tokay, S.
    Aydin, S.
    Toprak, A.
    Inanc, N.
    Khan, S.
    Fak, A. S.
    Direskeneli, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 373 - 373
  • [9] Is it safe for patients with rheumatoid arthritis to have no regular follow-up for 4 years?
    Hewlett, S
    Mitchell, K
    Hehir, M
    Kirwan, J
    Pollock, J
    Memel, D
    Bennett, B
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S211 - S211
  • [10] CARDIOVASCULAR RISK FACTOR PROFILE IN AN ITALIAN COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A THREE YEARS FOLLOW-UP
    Erba, G.
    Grosso, G.
    Valena, C. A.
    Riva, M.
    Allevi, E.
    Betelli, M.
    Facchetti, R.
    Mancia, G.
    Pozzi, M. R.
    Grassi, G.
    JOURNAL OF HYPERTENSION, 2015, 33 : E118 - E118
12345